hormone-based metabolic understanding
et al., 2022), and antibacterial actions (Tian et al., 2022)
It is administered daily and is less convenient than Semaglutide
Our experienced medical team will work with you to determine if semaglutide is appropriate for your health profile and weight loss goals
Cardiovascular Benefits For patients with existing cardiovascular risk factors or established heart disease, Wegovy's proven cardiovascular benefits may make it the preferred choice
Yet among the SBM states, several of the states (NY, CA, and MA) have more than one plan that covers Wegovy for obesity, and the estimated individuals enrolled in plans with coverage is nearly 800,000 in the SBM states, versus only about 70,000 in the plans that cover Wegovy in the FFM